Skip to main content
. 2023 May 19;14:1183641. doi: 10.3389/fimmu.2023.1183641

Figure 1.

Figure 1

Current methods used in the Glitipni study. The aim of the strategy is to combine surgical treatment with a combination of local and systemic immunotherapy by decreasing immunosuppression and inducing immune response. Currently employed immunotherapeutic agents in our trials include local, locoregional, and systemic immune checkpoint inhibitors and local myeloid dendritic cells (created with BioRender.com).